Patents by Inventor Kue-Hsiung Hsieh

Kue-Hsiung Hsieh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases
    Patent number: 6251663
    Abstract: The present invention relates to recombinant eukaryotic plasmids comprising an eukaryotic expression vector and an allergen gene for the prevention and/or treatment of allergic diseases. When the recombinant vector containing allergen-gene administrate to an individual in need of such prevention and/or treatment by intramuscular injection, intranasal delivery or intratracheal delivery, the production of allergen-specific IgE synthesis can be inhibited. The invention also relates to the pharmaceutical compositions comprising the the recombinant vector for use in the the prevention and/or treatment of allergic diseases and the production of allergen-specific IgE synthesis. A method for the prevention and/or treatment of allergic diseases is also provided.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: June 26, 2001
    Assignee: Jen Wen Co., Ltd.
    Inventors: Ching-Hsiang Hsu, Kaw-Yan Chua, Mi-Hua Tao, Kue-Hsiung Hsieh
  • Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases
    Patent number: 5958891
    Abstract: The present invention relates to recombinant eukaryotic plasmids comprising an eukaryotic expression vector and an allergen gene for the prevention and/or treatment of allergic diseases. When the recombinant vector containing allergen-gene is administered to an individual in need of such prevention and/or treatment by intramuscular injection, intranasal delivery or intratracheal delivery, the production of allergen-specific IgE synthesis can be inhibited. The invention also relates to the pharmaceutical compositions comprising the recombinant vector for use in the the prevention and/or treatment of allergic diseases and the production of allergen-specific IgE synthesis. A method for the prevention and/or treatment of allergic diseases is also provided.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: September 28, 1999
    Inventors: Ching-Hsiang Hsu, Kaw-Yan Chua, Mi-Hua Tao, Kue-Hsiung Hsieh